fundvisualizer.com

Nuveen Small/Mid-Cap Value CNSMCX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2024
Stock
89.36%
Non-U.S. Stock
6.32%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
4.32%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2024

Basic materials

4.37%

Consumer cyclical

4.95%

Financial services

18.33%

Real estate

11.44%

Consumer defensive

2.86%

Health care

8.99%

Utilities

4.36%

Communication services

3.84%

Energy

5.32%

Industrials

21.19%

Technology

10.00%

Top 10 holdings

As of 09/30/2024

Fixed Income Clearing Corp Repo
3.52%
ADMA Biologics Inc
3.46%
BGC Group Inc Ordinary Shares Class A
3.01%
Flowserve Corp
2.37%
Prosperity Bancshares Inc
2.25%
SouthState Corp
2.23%
Axis Capital Holdings Ltd
2.18%
Crane Co
2.16%
Seagate Technology Holdings PLC
2.15%
United Therapeutics Corp
2.04%
Fund assets

$108.53 Million

Share class

C

Morningstar category

Small Blend

Expense ratio

2.06%

Investment objective

Growth

Documents